Anthrax Research Today is a free monthly online journal that collates and summarizes the latest research about Anthrax, including details on bacillus anthracis, contagiousness, exposure, effects.

Volume 3 (2007), Issue 10 (October)

1. An automated front-end monitor for anthrax surveillance systems based on the rapid detection of airborne endospores.
   Biotechnol Bioeng, 98(4): 864-71. [Abstract] [Full-text]
2. Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis.
   Vaccine, 25(41): 7197-205. [Abstract] [Full-text]
3. Anthrax lethal toxin inhibits growth of and vascular endothelial growth factor release from endothelial cells expressing the human herpes virus 8 viral G protein coupled receptor.
   Clin Cancer Res, 13(19): 5926-34. [Abstract] [Full-text]
4. Potential use of inhibitors of bacteria spore germination in the prophylactic treatment of anthrax and Clostridium difficile-associated disease.
   Expert Rev Anti Infect Ther, 5(5): 783-92. [Abstract] [Full-text]
5. Cryo-electron microscopy study of bacteriophage T4 displaying anthrax toxin proteins.
   Virology, 367(2): 422-7. [Abstract] [Full-text]
6. Modeling and detection of respiratory-related outbreak signatures.
   BMC Med Inform Decis Mak, 7(1): 28. [Abstract] [Full-text]
7. Identification of the amino acid residues critical for specific binding of the bacteriolytic enzyme of gamma-phage, PlyG, to Bacillus anthracis.
   Biochem Biophys Res Commun, 363(3): 531-5. [Abstract] [Full-text]
8. Development of quantitative real-time PCR assays for detection and quantification of surrogate biological warfare agents in building debris and leachate.
   Appl Environ Microbiol, 73(20): 6557-65. [Abstract] [Full-text]
9. Anthrax vaccination in a military population before the war in Iraq: side effects and informed choice.
   Vaccine, 25(44): 7641-8. [Abstract] [Full-text]
10. Differential analysis of Bacillus anthracis after pX01 plasmid curing and comprehensive data on Bacillus anthracis infection in macrophages and glial cells.
    Proteomics, 7(20): 3743-58. [Abstract] [Full-text]
11. Complement c3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response.
    PLoS ONE, 2(10): e1044. [Abstract] [Full-text]
12. Antitumor activities of TEM8-Fc: an engineered antibody-like molecule targeting tumor endothelial marker 8.
    J Natl Cancer Inst, 99(20): 1551-5. [Abstract] [Full-text]
13. Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.
    Cancer Res, 67(20): 9980-5. [Abstract] [Full-text]
14. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Infect Immun, 75(11): 5425-33. [Abstract] [Full-text]
15. In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity.
    Infect Immun, 75(11): 5443-52. [Abstract] [Full-text]
16. Immunization by Application of DNA Vaccine onto a Skin Area Wherein the Hair Follicles Have Been Induced into Anagen-onset Stage.
    Mol Ther, 15(11): 2037-43. [Abstract] [Full-text]
17. Recombinant exosporium protein BclA of Bacillus anthracis is effective as a booster for mice primed with suboptimal amounts of protective antigen.
    Infect Immun, 75(11): 5240-7. [Abstract] [Full-text]
18. Anthrax protective antigen cleavage and clearance from the blood of mice and rats.
    Infect Immun, 75(11): 5175-84. [Abstract] [Full-text]
19. Microwave-accelerated metal-enhanced fluorescence: application to detection of genomic and exosporium anthrax DNA in <30 seconds.
    Analyst, 132(11): 1130-8. [Abstract] [Full-text]
20. Rapid generation of an anthrax immunotherapeutic from goats using a novel non-toxic muramyl dipeptide adjuvant.
    J Immune Based Ther Vaccines, 5(1): 11. [Abstract] [Full-text]
21. Isolation and selection of Bacillus spp. as potential biological agents for enhancement of water quality in culture of ornamental fish.
    J Appl Microbiol, 103(5): 1471-9. [Abstract] [Full-text]
22. A study of the physiology of Bacillus anthracis Sterne during manufacture of the UK acellular anthrax vaccine.
    J Appl Microbiol, 103(5): 1453-60. [Abstract] [Full-text]
23. Anthrax vaccine and public health policy.
    Am J Public Health, 97(11): 1945-51. [Abstract] [Full-text]
24. Quantitative inhibitor fingerprinting of metalloproteases using small molecule microarrays.
    J Am Chem Soc, 129(43): 13110-7. [Abstract] [Full-text]
25. A viral nanoparticle with dual function as an anthrax antitoxin and vaccine.
    PLoS Pathog, 3(10): 1422-31. [Abstract] [Full-text]

© 2005-2008 Anthrax Research Today. All Rights Reserved.